MA45461A - Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation - Google Patents

Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation

Info

Publication number
MA45461A
MA45461A MA045461A MA45461A MA45461A MA 45461 A MA45461 A MA 45461A MA 045461 A MA045461 A MA 045461A MA 45461 A MA45461 A MA 45461A MA 45461 A MA45461 A MA 45461A
Authority
MA
Morocco
Prior art keywords
aminomethyl
preparation process
crystalline form
tetracycline compounds
form substituted
Prior art date
Application number
MA045461A
Other languages
English (en)
Inventor
Mei Hong
Zhenhua Huang
Chen Jiang
Original Assignee
Kbp Biosciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kbp Biosciences Co Ltd filed Critical Kbp Biosciences Co Ltd
Publication of MA45461A publication Critical patent/MA45461A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54—Spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
MA045461A 2016-06-22 2017-06-22 Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation MA45461A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610457261 2016-06-22

Publications (1)

Publication Number Publication Date
MA45461A true MA45461A (fr) 2019-05-01

Family

ID=60783195

Family Applications (1)

Application Number Title Priority Date Filing Date
MA045461A MA45461A (fr) 2016-06-22 2017-06-22 Forme cristalline de 9-aminométhyle substitués des composés de tetracycline et leur procédé de préparation

Country Status (21)

Country Link
US (1) US10633337B2 (fr)
EP (1) EP3476831B8 (fr)
JP (1) JP6883593B2 (fr)
KR (1) KR102205843B1 (fr)
CN (1) CN109563035B (fr)
AU (1) AU2017282891B2 (fr)
CA (1) CA3028014C (fr)
CL (1) CL2018003739A1 (fr)
CO (1) CO2019000513A2 (fr)
ES (1) ES2906885T3 (fr)
IL (1) IL263868B (fr)
MA (1) MA45461A (fr)
MX (1) MX381701B (fr)
MY (1) MY186900A (fr)
PE (1) PE20190810A1 (fr)
PH (1) PH12018502680A1 (fr)
RU (1) RU2764723C2 (fr)
SG (1) SG11201811499WA (fr)
TW (1) TWI656116B (fr)
WO (1) WO2017219994A1 (fr)
ZA (1) ZA201900274B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD962414S1 (en) 2020-02-28 2022-08-30 Beijing Xiaomi Mobile Software Co., Ltd Fan
US20230357135A1 (en) * 2020-06-11 2023-11-09 Paratek Pharmaceuticals, Inc. Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064728A2 (fr) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Composes de tetracycline possedant des activites therapeutiques ciblees
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
ES2532880T3 (es) * 2007-11-14 2015-04-01 Sandoz Ag Formas cristalinas del Clorhidrato de Tigeciclina
WO2009092680A2 (fr) * 2008-01-23 2009-07-30 Sandoz Ag Composés antibiotiques
TWI585071B (zh) * 2008-05-19 2017-06-01 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
EP2738156B1 (fr) * 2011-07-26 2018-01-03 Kbp Biosciences Usa Inc. Composés tétracycline substitué par 9-aminométhyle
CN102417465B (zh) * 2011-10-27 2014-03-12 宫宁瑞 替加环素新晶型及其制备方法

Also Published As

Publication number Publication date
MX2019000086A (es) 2019-05-02
RU2764723C2 (ru) 2022-01-19
NZ749495A (en) 2020-12-18
RU2019101248A (ru) 2020-07-22
IL263868B (en) 2022-08-01
BR112018076726A2 (pt) 2019-04-02
US20190241515A1 (en) 2019-08-08
EP3476831A4 (fr) 2019-11-27
JP2019520363A (ja) 2019-07-18
KR102205843B1 (ko) 2021-01-22
EP3476831B1 (fr) 2021-11-17
TWI656116B (zh) 2019-04-11
ES2906885T3 (es) 2022-04-20
JP6883593B2 (ja) 2021-06-09
CN109563035B (zh) 2021-07-20
RU2019101248A3 (fr) 2020-07-22
US10633337B2 (en) 2020-04-28
PH12018502680A1 (en) 2019-10-14
AU2017282891A1 (en) 2019-01-17
CO2019000513A2 (es) 2019-04-30
EP3476831B8 (fr) 2021-12-29
RU2022100160A (ru) 2022-03-16
ZA201900274B (en) 2020-05-27
SG11201811499WA (en) 2019-01-30
WO2017219994A1 (fr) 2017-12-28
MY186900A (en) 2021-08-26
MX381701B (es) 2025-03-13
PE20190810A1 (es) 2019-06-13
AU2017282891B2 (en) 2020-01-02
KR20190024900A (ko) 2019-03-08
TW201800393A (zh) 2018-01-01
CA3028014C (fr) 2021-09-07
IL263868A (en) 2019-01-31
EP3476831A1 (fr) 2019-05-01
CA3028014A1 (fr) 2017-12-28
CL2018003739A1 (es) 2019-04-05
CN109563035A (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
EP3372606A4 (fr) Forme cristalline, procédé de préparation et intermédiaire d'un composé à cycle dihydropyridine
EP3470400A4 (fr) Forme cristalline de l'ozanimod, forme cristalline de son hydrochloride et son procédé de préparation
EP3546489A4 (fr) Polypropylène et son procédé de préparation
EP3516713A4 (fr) Procédé de préparation d'ensembles d'électrodes
EP3647312A4 (fr) Forme cristalline d'azd9291 deutéré, procédé de préparation associé et utilisation correspondante
EP3383436A4 (fr) Procédé amélioré de préparation de vert d'indocyanine
EP3412672A4 (fr) Forme cristalline a d'un agoniste de tlr7, son procédé de préparation et son utilisation
EP3502103A4 (fr) Forme cristalline, type de sel d'un dérivé de 2-hydro-pyrazole substitué et son procédé de préparation
EP3572441A4 (fr) Homopolypropylène et son procédé de préparation
EP3453703A4 (fr) Forme cristalline e d'un sel de tafamidis méthylglucamine, son procédé de préparation et son application
EP3327025A4 (fr) Forme a cristalline de rebaudioside d, et son procédé de préparation et son application
EP3694499A4 (fr) Nouveau procédé de préparation de lifitegrast
EP2958883A4 (fr) Compositions de cyclohexénone et leur procédé de préparation
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
EP3500551A4 (fr) Procédé de préparation de biphényles substitués
EP3294310A4 (fr) Composition oléorésineuse en poudre hautement concentrée et procédé de préparation de cette composition
EP3511313A4 (fr) Procédé de préparation de 1,3-cyclohexanediméthanol
EP3504221A4 (fr) Nouveau procédé de préparation de corticostéroïdes
EP3770239A4 (fr) Procédé de préparation de microcapsules
EP3395811A4 (fr) Cristaux de dérivé quinazoline et leur procédé de préparation
EP3505525A4 (fr) Procédé de préparation de rubusoside
MA48944A (fr) Forme cristalline de n-butyldéoxygalactonojirimycine
EP3398592A4 (fr) Préparation topique et son procédé de production
EP3519382A4 (fr) Procédé amélioré de préparation de lacosamide
EP3461822A4 (fr) Forme cristalline de composé chimique, son procédé de préparation, sa composition et son application